1. Home
  2. POCI vs RNXT Comparison

POCI vs RNXT Comparison

Compare POCI & RNXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Precision Optics Corporation Inc.

POCI

Precision Optics Corporation Inc.

HOLD

Current Price

$4.13

Market Cap

31.9M

Sector

Health Care

ML Signal

HOLD

Logo RenovoRx Inc.

RNXT

RenovoRx Inc.

HOLD

Current Price

$0.95

Market Cap

36.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
POCI
RNXT
Founded
1982
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
31.9M
36.4M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
POCI
RNXT
Price
$4.13
$0.95
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$7.75
AVG Volume (30 Days)
25.7K
295.1K
Earning Date
11-13-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$21,575,039.00
$928,000.00
Revenue This Year
N/A
$2,795.35
Revenue Next Year
N/A
$272.69
P/E Ratio
N/A
N/A
Revenue Growth
13.67
N/A
52 Week Low
$3.77
$0.70
52 Week High
$5.34
$1.69

Technical Indicators

Market Signals
Indicator
POCI
RNXT
Relative Strength Index (RSI) 41.47 51.11
Support Level $4.07 $0.92
Resistance Level $4.56 $0.93
Average True Range (ATR) 0.26 0.06
MACD -0.04 0.02
Stochastic Oscillator 16.50 76.75

Price Performance

Historical Comparison
POCI
RNXT

About POCI Precision Optics Corporation Inc.

Precision Optics Corp Inc is engaged in designing, developing, and manufacturing advanced optical instruments. It manufactures medical products such as endoscopes and endocouplers which incorporate various optical technologies for use in a variety of minimally invasive surgical and diagnostic procedures. The company also produces endoscopes for various applications as well as designs and manufactures custom optical medical devices to satisfy customers' specific requirements. In addition, the company manufactures and sells components and assemblies specially designed for industrial and military use. The company earns the majority of its revenue from the United States.

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

Share on Social Networks: